Siegelmann-Danieli, N., Silverman, B., Zick, A., Beit-Or, A., Katzir, I., & Porath, A. (2013). The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer: The Maccabi Healthcare Services experience with a unified testing policy. Cancer Intelligence.
Citação norma ChicagoSiegelmann-Danieli, Nava, Barbara Silverman, Aviad Zick, Anat Beit-Or, Itzhak Katzir, and Avi Porath. The Impact of the Oncotype DX Recurrence Score On Treatment Decisions and Clinical Outcomes in Patients With Early Breast Cancer: The Maccabi Healthcare Services Experience With a Unified Testing Policy. Cancer Intelligence, 2013.
Citação norma MLASiegelmann-Danieli, Nava, et al. The Impact of the Oncotype DX Recurrence Score On Treatment Decisions and Clinical Outcomes in Patients With Early Breast Cancer: The Maccabi Healthcare Services Experience With a Unified Testing Policy. Cancer Intelligence, 2013.